DuoTrav

DuoTrav Dosage/Direction for Use

travoprost + timolol

Manufacturer:

Novartis

Distributor:

Zuellig
/
Firma Chun Cheong
Full Prescribing Info
Dosage/Direction for Use
Posology: Use in adults, including the elderly: The dose is one drop of DuoTrav eye drops in the conjunctival sac of the affected eye(s) once daily, in the morning or evening. It should be administered at the same time each day.
If a dose is missed, treatment should be continued with the next dose as planned. The dose should not exceed one drop in the affected eye(s) daily.
Special populations: Hepatic and renal impairment: No studies have been conducted with DuoTrav eye drops or with timolol 5 mg/mL eye drops in patients with hepatic or renal impairment.
Travoprost has been studied in patients with mild to severe hepatic impairment and in patients with mild to severe renal impairment (creatinine clearance as low as 14 mL/min). No dose adjustment was necessary in these patients.
Patients with hepatic or renal impairment are unlikely to require dose adjustment with DuoTrav eye drops (see Pharmacology: Pharmacokinetics under Actions).
Paediatric population: The safety and efficacy of DuoTrav eye drops in children and adolescents below the age of 18 years have not been established. No data are available.
Method of administration: For ocular use.
The patient should remove the protective overwrap immediately prior to initial use. To prevent contamination of the dropper tip and solution, care must be taken not to touch the eyelids, surrounding areas or other surfaces with the dropper tip of the bottle.
When nasolacrimal occlusion is used or the eyelids are closed for 2 minutes, systemic absorption is reduced. This may result in a decrease in systemic side effects and an increase in local activity (see Precautions).
If more than one topical ophthalmic medicinal product is being used, the medicinal products must be administered at least 5 minutes apart (see Interactions).
When substituting another ophthalmic antiglaucoma medicinal product with DuoTrav eye drops, the other medicinal product should be discontinued and DuoTrav eye drops should be started the following day.
Patients must be instructed to remove soft contact lenses prior to application of DuoTrav eye drops and wait 15 minutes after instillation of the dose before reinsertion (see Precautions).
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in